Ilya Pharma will be attending the Accelerating Bio-Innovation in Boston June 22-25.
The company will be presented along with a process update on the lead program of ILP100-Topical in SAVI and the new project of ILP101 targeting lung disease.
Conference website: https://abiconference.com/about/